Logotype for Corteva Inc

Corteva (CTVA) Q3 2024 earnings summary

Event summary combining transcript, slides, and related documents.

Logotype for Corteva Inc

Q3 2024 earnings summary

15 Jan, 2026

Executive summary

  • Third quarter 2024 results were in line with expectations, with net sales down 10% year-over-year to $2.33B, reflecting challenging dynamics in Latin America and competitive pricing pressures.

  • Operating loss was reported for Q3, but strong execution led to over $400M in controllable cost savings for the year.

  • Seed business showed robust performance in North America with pricing and share gains, while Crop Protection delivered margin growth and benefited from demand for differentiated technology.

  • Full-year 2024 guidance was updated to reflect lower revenue expectations due to Latin America headwinds, but margin stability was supported by cost improvements and operational execution.

  • Preliminary 2025 outlook anticipates double-digit operating EBITDA growth and margin expansion, driven by new product gains, cost deflation, and continued investment in innovation.

Financial highlights

  • Q3 2024 net sales declined 10% year-over-year to $2.33B; YTD net sales down 4% to $12.9B.

  • Q3 2024 operating EBITDA was $(100)M, with a margin of (4.3)%; YTD operating EBITDA was $2.85B, down 5%, with a 22% margin.

  • Q3 2024 GAAP loss from continuing operations was $519M; YTD net income from continuing operations was $913M, down 22%.

  • Q3 2024 diluted loss per share was $(0.76); YTD diluted EPS was $1.29, down 21%.

  • Q3 2024 cost of goods sold was $1,565M, down from $1,646M in Q3 2023, mainly due to favorable currency, cost actions, and raw material deflation.

Outlook and guidance

  • Full-year 2024 net sales expected at $17.0–$17.2B, down 1% at midpoint; operating EBITDA forecasted at $3.35–$3.45B, up 1% at midpoint.

  • Operating EPS expected in the range of $2.50–$2.60, down 5% at midpoint.

  • Free cash flow guidance reaffirmed at $1.5–$2.0B; cash from operations projected at $2.1B–$2.6B.

  • 2025 preliminary outlook: net sales $17.3–$17.7B, operating EBITDA $3.6–$4.0B, with double-digit EBITDA growth and margin expansion.

  • $400M cost improvements expected in 2025, driven by lower commodity costs, deflation, and productivity.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
All investor relations material. One API.
Learn more